Risperdal Lawsuit

What Is Risperdal

Manufactured and distributed by a subsidiary of Johnson & Johnson, Ortho-McNeill-Janssen Pharmaceuticals, Risperdal is an antipsychotic prescription only medication. Risperidone is the active Risperdal ingredient. Risperdal is advertised as being able to help with:

  • Autistic Children
  • Bipolar 1 Disorder in Patients 10 Years or Older
  • Teenage Schizophrenia
  • Adult Schizophrenia
  • Back in 2004, the patent expired for Janssen Pharmaceuticals, which then allowed for the manufacturing and distribution of a Risperdal generic equivalent to be done by Teva Pharmaceuticals.

    Risperdal Controversy

    There’s an increasing amount of Risperdal controversy being experienced. For instance, Risperdal is used for dementia management; however, it significantly increases the likelihood of users dying from other diseases, including heart disease and pneumonia. Due to an odd odor found in a manufacturing run of Risperdal, there were 16,000 approximate bottles recalled by Janssen Pharmaceuticals. They believe the odor came from the chemical tribromoanisole (TBA). Trace TBA amounts causing the contamination is suspected to have happened during the shipping process from wooden pallets. Wooden pallets are often coated with TBA, which lead to the contamination.

    Risperdal Litigation

    A claim was filed against Johnson & Johnson in January of 2010, by various whistleblowers, the Department of Justice and the state’s attorney general. The lawsuit claimed that there was $50 million dollars’ worth of financial incentives/kickbacks to Omnicare by Johnson & Johnson. Omnicare (a pharmaceutical supply company) orchestrated all of the programs that convinced the prescription of Risperdal by doctors to their nursing home patients. There was a settlement of the allegations when Omnicare paid out $112 million.

    It’s reported that there are substantial funds that have been set aside by Johnson & Johnson for liability expenses in Risperdal cases. Massachusetts filed a Risperdal lawsuit against Johnson & Johnson in August of 2011. This claim stated that Risperdal was marketed for off-label and unapproved uses by Johnson & Johnson. Additionally, the lawsuit claims that adequate warnings of dangerous side effects were not provided to consumers. Of the side effects of Risperdal cited in the case are at greater death risk for elderly patients and diabetes. There are also other states that have filed lawsuits over Risperdal, including South Carolina and West Virginia.

    Risperdal Whistleblower

    The wheels were taken off the Risperdal bus when Allen Jones acted as a whistleblower that Johnson & Johnson had been soliciting state officials to make Risperdal recommendations to foster children. If it were successful Medicaid programs in Pennsylvania and Texas would have paid for the expenses of the Risperdal. The reactions of the discoveries in the two states and the discoveries of Jones were different and drastically so. Jones received the Whistleblower of the Year and out of the $158 million dollar Johnson & Johnson settlement, he received $20 million. The scandal was not deemed to be a concern within the state of Pennsylvania. He was not only shunned by officials in the state, but he also lost his job.

    Breast Tissue Growth

    Johnson & Johnson has several pending lawsuits that have been filed for male patient breast tissue growth. A young man, in a Risperdal case that was filed in Philadelphia County Court of Common Pleas, makes the claim that he was given a prescription for Risperdal at the age of 9 in 2000. He took the antipsychotic for four years until 2004. During the time he was on the drug, it had not been approved for any use by children.

    In the complaint he also states that he’s had to suffer, as a result of the Risperdal, gynecomastia. Gynecomastia is a condition that leads to males developing breast tissues. Additionally, the claim makes the assertion that Johnson & Johnson was negligent by their failure to warn the consumer about the serious risks to their safety. Furthermore, the claim asserts that inadequately reported, or concealed, side effects of the drug include:

    • Pancreatitis
    • Weight Gain
    • Metabolic Syndrome
    • Gynecomastia
    • Diabetes Mellitus
    • Hyperprolactinemia
    • Tardive Dyskinesia
    • Other Types of Heath Risks

    The first day of trial the Risperdal case was settled for an undisclosed amount. Have you or a loved one been prescribed and taken Risperdal? Contact us today for a free consultation.